Cite
HARVARD Citation
Zhou, T. et al. (2022). A novel EGFR exon 21 indel mutation in lung adenocarcinoma and response to dacomitinib: A case report. Medicine. 101 (34), pp. e30269-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhou, T. et al. (2022). A novel EGFR exon 21 indel mutation in lung adenocarcinoma and response to dacomitinib: A case report. Medicine. 101 (34), pp. e30269-. [Online].